| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB108891-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF10774-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB10889-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26918-0.025mg | |||
![Western Blot: SARS-CoV-2 Spike Antibody [NBP2-41058] - Validation in Spike Transfected 293 Cells Loading: 15 ug per lane of 293 cell lysate. SARS-CoV-2 Spike(1ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: WT 293 cells and Lane 2: SARS-CoV-2 Spike overexpressed 293 cells](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-Western-Blot-NBP2-41058-img0001.jpg "Western Blot: SARS-CoV-2 Spike Antibody [NBP2-41058] - Validation in Spike Transfected 293 Cells Loading: 15 ug per lane of 293 cell lysate. SARS-CoV-2 Spike(1ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: WT 293 cells and Lane 2: SARS-CoV-2 Spike overexpressed 293 cells")
![Immunohistochemistry-Paraffin: SARS-CoV-2 Spike Antibody [NBP2-41058] - Immunohistochemistry Validation of SARS-CoV-2 Spike in COVID-19 Patient Lung. Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 Spike S2 antibody (NBP2-41058, 0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong spike protein signal was observed in macrophages of COVID-19 patient lung.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-Immunohistochemistry-Paraffin-NBP2-41058-img0003.jpg)
![Immunohistochemistry-Paraffin: SARS-CoV-2 Spike Antibody [NBP2-41058] - Immunohistochemistry Validation of SARS-CoV-2 Spike in COVID-19 Patient Lung. Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 Spike S2 antibody (NBP2-41058, 0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong spike protein signal was observed in macrophages and airway epithelium of COVID-19 patient lung, but not in non-COVID-19 patient lung.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-Antibody-Immunohistochemistry-Paraffin-NBP2-41058-img0002.jpg)
![ELISA: SARS-CoV-2 Spike Antibody - BSA Free [NBP2-41058] - Figure 14 ELISA TestAntibodies: SARS-CoV-2 (COVID-19) Spike antibody, (1 u/mL). A direct ELISA was performed using immunogen or control peptide as coating antigen and the anti-SARS-CoV-2 (COVID-19) Spike antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.5 ng/mL to 1000 ng/mL.](http://images.novusbio.com/fullsize/nbp2-41058_rabbit-polyclonal-sars-cov-2-spike-antibody-271120241958462.jpg)
![Immunocytochemistry/ Immunofluorescence: SARS-CoV-2 Spike Antibody - BSA Free [NBP2-41058] - Validation of SARS-CoV-2 (COVID-19) Spike in 293T Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed 293T cells labeling SARS-CoV-2 (COVID-19) Spike with at 1 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp2-41058_rabbit-polyclonal-sars-cov-2-spike-antibody-271120242022975.jpg)
![Western Blot: SARS-CoV-2 Spike S2 Antibody [NBP3-05701] - Overexpression Validation in Spike Transfected 293 Cells. Loading: 10 ug per lane of Spike transfected 293 cell lysate. Antibodies: SARS-CoV-2 Spike S2, NBP3-05701, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: 1 ug/mL and Lane 2: 2 ug/mL](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-S2-Antibody-Western-Blot-NBP3-05701-img0004.jpg "Western Blot: SARS-CoV-2 Spike S2 Antibody [NBP3-05701] - Overexpression Validation in Spike Transfected 293 Cells. Loading: 10 ug per lane of Spike transfected 293 cell lysate. Antibodies: SARS-CoV-2 Spike S2, NBP3-05701, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: 1 ug/mL and Lane 2: 2 ug/mL")
![Immunohistochemistry-Paraffin: SARS-CoV-2 Spike S2 Antibody [NBP3-05701] - Immunohistochemistry Validation of SARS-CoV-2 Spike S2 in COVID-19 Patient Lung. Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 Spike S2 antibody (NBP3-05701, 0.1 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 spike protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-S2-Antibody-Immunohistochemistry-Paraffin-NBP3-05701-img0002.jpg)
![Western Blot: SARS-CoV-2 Spike S2 Antibody [NBP3-05701] - Western Blot Validation with SARS-CoV-2 Spike S2 ECD Recombinant Protein. Loading: 30 ng per lane of SARS-CoV-2 Spike S2 ECD recombinant protein. Antibodies: SARS-CoV-2 Spike S2, NBP3-05701, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: 1 ug/mL and Lane 2: 2 ug/mL.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-S2-Antibody-Western-Blot-NBP3-05701-img0003.jpg)
![ELISA: SARS-CoV-2 Spike S2 Antibody [NBP3-05701] - Validation with SARS-CoV-2 Spike S2 ECD Recombinant ProteinSARS-CoV-2 Spike S2 antibody, 9123. A direct ELISA was performed using SARS-CoV-2 Spike S2 ECD recombinant protein as coating antigen and the anti-SARS-CoV-2 Spike S2 antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 8 ng/mL to 1000ng/mL.](http://images.novusbio.com/fullsize/SARS-CoV-2-Spike-S2-Antibody-ELISA-NBP3-05701-img0001.jpg)
![Immunohistochemistry: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Validation of SARS-CoV-2 Spike S1 in COVID-19 Patient Lung. Analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 Spike S1 antibody (0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 spike protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.](http://images.novusbio.com/fullsize/nbp3-26918_rabbit-sars-cov-2-spike-s1-pab-bsa-free-242024161943.jpg "Immunohistochemistry: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Validation of SARS-CoV-2 Spike S1 in COVID-19 Patient Lung. Analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 Spike S1 antibody (0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 spike protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.")
![Western Blot: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Validation with SARS-CoV-2 Spike Recombinant Protein. Loading: 50 ng per lane of SARS-CoV-2 Spike S1 recombinant protein. Antibodies: SARS-CoV-2 Spike S1, NBP3-26918, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: 1 ug/mL and Lane 2: 2 ug/mL.](http://images.novusbio.com/fullsize/nbp3-26918_rabbit-sars-cov-2-spike-s1-pab-bsa-free-242024161944.jpg)
![ELISA: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Validation with SARS-CoV-2 Spike Recombinant Protein. Antibodies: SARS-CoV-2 Spike S1 antibody, NBP3-26918. A direct ELISA was performed using SARS-CoV-2 (COVID-19) Spike S1 recombinant protein as coating antigen and the anti-SARS-CoV-2 Spike S1 antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 8 ng/mL to 1000 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26918_rabbit-sars-cov-2-spike-s1-pab-bsa-free-242024161940.jpg)
![Immunocytochemistry/Immunofluorescence: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Validation of SARS-CoV-2 Spike S1 in 293 Transfected Cells. Analysis of 4% paraformaldehyde-fixed Spike transfected 293 cells labeling SARS-CoV-2 Spike S1 with NBP3-26918 at 5 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp3-26918_rabbit-sars-cov-2-spike-s1-pab-bsa-free-242024161942.jpg)
![Western Blot: SARS-CoV-2 Spike S1 Antibody - BSA Free [NBP3-26918] - Overexpression Validation in Spike Transfected 293 Cells. Loading: 10 ug per lane of 293 cell lysate. Antibodies: SARS-CoV-2 Spike S1, NBP3-26918 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: WT 293 cells and Lane 2: SARS-CoV-2 Spike overexpressed 293 cells.](http://images.novusbio.com/fullsize/nbp3-26918_rabbit-sars-cov-2-spike-s1-pab-bsa-free-242024161941.jpg)
